Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/13361
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Laffleur F. | |
dc.contributor.author | Zilio M. | |
dc.contributor.author | Shuwisitkul D. | |
dc.date.accessioned | 2021-04-05T03:23:30Z | - |
dc.date.available | 2021-04-05T03:23:30Z | - |
dc.date.issued | 2016 | |
dc.identifier.issn | 20415990 | |
dc.identifier.other | 2-s2.0-84994152086 | |
dc.identifier.uri | https://ir.swu.ac.th/jspui/handle/123456789/13361 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84994152086&doi=10.4155%2ftde-2016-0046&partnerID=40&md5=91cb891f84d0ec1c5d23949d515caff7 | |
dc.description.abstract | Aim: Doxepin is a traditional tricyclic antidepressant with analgesic and anesthetic properties when applied topically to the mucosa. Doxepin is one approach in treating insomnia and depression in Parkinson's disease. Patients with Parkinson's disease suffer difficulties in swallowing. Therefore, it was the aim of this study to develop a buccal-adhesive delivery system. Methods: Pectin was modified with cysteine. Stability assays in form of disintegration assay according to the Ph.Eur were performed. Furthermore, bioadhesiveness on buccal mucosa was investigated incorporating the drug doxepin. Results: The adhesiveness was improved 1.4-fold and revealed a sustained release over 3 h. Conclusion: Taking these findings into account, the modifications render this designed excipient fruitful for buccal delivery. © 2016 Future Science Ltd. | |
dc.subject | cysteine | |
dc.subject | disulfide | |
dc.subject | doxepin | |
dc.subject | pectin | |
dc.subject | doxepin | |
dc.subject | drug carrier | |
dc.subject | animal tissue | |
dc.subject | Article | |
dc.subject | cell viability | |
dc.subject | cheek mucosa | |
dc.subject | comparative study | |
dc.subject | controlled study | |
dc.subject | disulfide bond | |
dc.subject | drug delivery system | |
dc.subject | gravimetry | |
dc.subject | infrared spectroscopy | |
dc.subject | mucoadhesion | |
dc.subject | nonhuman | |
dc.subject | pH | |
dc.subject | polymerization | |
dc.subject | priority journal | |
dc.subject | resazurin assay | |
dc.subject | surface property | |
dc.subject | sustained drug release | |
dc.subject | synthesis | |
dc.subject | adhesion | |
dc.subject | buccal drug administration | |
dc.subject | cell culture | |
dc.subject | cell survival | |
dc.subject | chemistry | |
dc.subject | drug effects | |
dc.subject | drug release | |
dc.subject | drug stability | |
dc.subject | human | |
dc.subject | mouth mucosa | |
dc.subject | Adhesiveness | |
dc.subject | Administration, Buccal | |
dc.subject | Cell Survival | |
dc.subject | Cells, Cultured | |
dc.subject | Cysteine | |
dc.subject | Doxepin | |
dc.subject | Drug Carriers | |
dc.subject | Drug Liberation | |
dc.subject | Drug Stability | |
dc.subject | Humans | |
dc.subject | Mouth Mucosa | |
dc.subject | Pectins | |
dc.title | Modified biomolecule as potential vehicle for buccal delivery of doxepin | |
dc.type | Article | |
dc.rights.holder | Scopus | |
dc.identifier.bibliograpycitation | Therapeutic Delivery. Vol 7, No.10 (2016), p.683-689 | |
dc.identifier.doi | 10.4155/tde-2016-0046 | |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.